title: Can nifedipine and estrogen interaction with imatinib be responsible for gallbladder stone development?
authors.forename: Massimo
authors.initials: M
authors.lastname: Breccia
authors.forename: Mariella
authors.initials: M
authors.lastname: D'Andrea
authors.forename: Giuliana
authors.initials: G
authors.lastname: Alimena
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001549:Benzamides; D004347:Drug Interactions; D004967:Estrogens / Q000008:administration & dosage*; D005260:Female; D042882:Gallstones / Q000139:chemically induced; D006801:Humans; D000068877:Imatinib Mesylate; D008297:Male; D009543:Nifedipine / Q000008:administration & dosage*; D010879:Piperazines / Q000008:administration & dosage*; D011743:Pyrimidines / Q000008:administration & dosage*; D015149:Tocolytic Agents / Q000008:administration & dosage*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D004967:Estrogens; D010879:Piperazines; D011743:Pyrimidines; D015149:Tocolytic Agents; D000068877:Imatinib Mesylate; D009543:Nifedipine